PENNINGTON BIOMEDICAL RESEARCH
EIN: 58-1767810Baton Rouge, LAZIP: 70808
H92Z - Medical Research501(c)(3)
Mission
THE MISSION OF THE PENNINGTON BIOMEDICAL RESEARCH FOUNDATION IS TO SUPPORT THE WORK OF LSU'S PENNINGTON BIOMEDICAL RESEARCH CENTER, WHICH AIMS TO DISCOVER THE TRIGGERS OF CHRONIC DISEASES THROUGH INNOVATIVE REASEARCH THAT IMPROVES HUMAN HEALTH.
Financials
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2023 | $5.8M | $0 | $29.5M |
| 2022 | $4.8M | $0 | $26.2M |
Compensation
2023
2022
Similar Organizations
IMPROVECARENOW INC
$3.7M revenueEssex, VT
Similar sector (H)Comparable revenue ($3.7M vs $5.8M)Similar median compensation ($156k vs $163k)
FLORIDA BREAST CANCER COALITION RESEARCH
$3M revenueNorth Miami, FL
Similar sector (H)Comparable revenue ($3M vs $5.8M)Similar median compensation ($142k vs $163k)
HUMAN IMMUNOME PROJECT INC
$3M revenueNew York, NY
Similar sector (H)Comparable revenue ($3M vs $5.8M)Similar median compensation ($184k vs $163k)
ALPHA OMICRON PI FOUNDATION
$3M revenueBrentwood, TN
Similar sector (H)Comparable revenue ($3M vs $5.8M)Similar median compensation ($179k vs $163k)
WELLCOME LEAP INC
$3.1M revenueCulver City, CA
Similar sector (H)Comparable revenue ($3.1M vs $5.8M)Similar median compensation ($179k vs $163k)
PSFC
$3.2M revenueSan Francisco, CA
Similar sector (H)Comparable revenue ($3.2M vs $5.8M)Similar median compensation ($171k vs $163k)
The Curetivity Foundation
$3.2M revenueDarien, CT
Similar sector (H)Comparable revenue ($3.2M vs $5.8M)Similar median compensation ($150k vs $163k)
HEALTHCORPS INC
$3.3M revenueNew York, NY
Similar sector (H)Comparable revenue ($3.3M vs $5.8M)Similar median compensation ($172k vs $163k)
ST LOUIS INTEGRATED HEALTH NETWORK
$3.4M revenueSt Louis, MO
Similar sector (H)Comparable revenue ($3.4M vs $5.8M)Similar median compensation ($142k vs $163k)
FOUNDATION FOR ORTHOPAEDIC RESEARCH
$3.5M revenueTampa, FL
Similar sector (H)Comparable revenue ($3.5M vs $5.8M)Similar median compensation ($155k vs $163k)
Data from IRS Form 990 filings (2022-2023).